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The glycoprotein gene of Ebola virus contains a translational stop codon in the middle, thus preventing synthesis of full-
length glycoprotein. Twenty percent of the mRNA isolated from Ebola virus-infected cells was shown to be edited, containing
one additional nontemplate A in a stretch of seven consecutive A residues. Only the edited mRNA species encoded full-
length glycoprotein, whereas the exact copies of the viral template coded for a smaller secreted glycoprotein. Expression
of the glycoprotein by an in vitro transcription/translation system, by the vaccinia virus/T7 polymerase system, and by
recombinant vaccinia virus revealed that full-length glycoprotein was synthesized not only when the edited glycoprotein
gene (8A’s) was used as a template for T7 and vaccinia virus polymerases, but also when the nonedited (genomic) glycopro-
tein gene was used. Analysis of mRNA produced by T7 and vaccinia virus polymerase from the 7A’s construct revealed
that 1–5% contained alterations at the same site that was also edited by the Ebola virus polymerase. Our data indicate
that the editing site in the Ebola virus glycoprotein gene is recognized not only by Ebola virus polymerase but also by DNA-
dependent RNA polymerases of different origin. q 1995 Academic Press, Inc.
INTRODUCTION It can be assumed that, in analogy to MBG, GP of EBO
is present in the viral membrane as homotrimers that
Ebola virus (EBO), which together with Marburg virus make up the virion surface spikes (Feldmann et al., 1991).
(MBG) constitutes the family Filoviridae, is known to be Recently it was shown (Volchkov et al., 1992; Will et al.,
an extremely pathogenic agent, causing a severe hemor- 1992) that GP of filoviruses contains a stretch of 26 amino
rhagic disease in humans and monkeys with high mortal- acids (aa) in the C-terminal region with a high degree of
ity rates (Bowen et al., 1977; Johnson et al., 1977). EBO homology to an immunosuppressive motif found in the
is an enveloped, single-stranded, negative-sense RNA
p15E-related glycoproteins of oncogenic retroviruses
virus (Kiley et al., 1988; Peters et al., 1994). EBO particles
(Cianciolo et al., 1985; Kadota et al., 1991) which may
consist of at least seven structural proteins: the L protein
contribute to the high pathogenicity of EBO and MBG.
(L), the glycoprotein (GP), the nucleoprotein (NP), and
There is evidence obtained from nucleotide sequencefour other structural proteins, VP40, VP35, VP30, and
analyses suggesting that expression of GP involves inter-VP24. The corresponding genes are located on the viral
esting mechanisms at the transcriptional or translationalRNA in the following linear order: 3*-NP–VP35–VP40–
level and that variations in the expression strategies ofGP–VP30–VP24–L-5* (Sanchez et al., 1993; Volchkov et
this gene exist. Sanchez and co-workers (1993) showedal., 1992, 1993; Feldmann et al., 1993). All genes are
originally that full-length GP of the EBO Zaire was en-transcribed into monocistronic polyadenylated messen-
coded by a single open reading frame (ORF). In contrast,ger RNAs.
a study carried out on the same strain by Volchkov andGP of EBO is highly glycosylated with an Mr of 125–
co-workers (1993) indicated that GP was expressed from140 kDa, when analyzed by sodium dodecyl sulfate
two ORFs that are present in different frames. Two ORFs(SDS)–polyacrylamide gel electrophoresis (PAGE) (Elliott
were also observed in a subsequent study of the Ameri-et al., 1985). Since GP is the only surface protein it is
can group on EBO subtypes Sudan and Reston as wellsupposed to be responsible for receptor binding and
as on virus of the subtype Zaire with a different passagemembrane fusion during entry of the virus into host cells.
history (Peters et al., 1994). Furthermore, these authors
obtained evidence that the primary gene product of the
GP is not full-length GP, but a smaller nonstructural gly-Nucleotide sequence data from this article have been deposited with
the EMBL/GenBank Data Libraries under Accession No. U31033. coprotein that is secreted from infected cells (sGP).
1 Presented in part at IXth International Congress of Virology, Glas-
There are two different mechanisms by which a proteingow, Scotland, August 8–13, 1993 (Abstract P52-2).
is expressed from different ORFs: mRNA editing as de-2 To whom correspondence and reprint requests should be ad-
dressed. scribed for the P gene of paramyxoviruses, also belong-
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ing to the mononegavirales (Thomas et al., 1988; Vidal mRNA sense), supplied with a 5*-terminal HindIII site to
facilitate cloning.et al., 1990a; Cattaneo et al., 1989; Paterson and Lamb,
1990) or ribosomal frame shifting as occurring with the
gag–pol protein of retroviruses (Jacks et al., 1988a,b; Isolation, cloning, and sequencing of EBO GP-specific
Wilson et al., 1988). mRNA
In order to investigate the mechanism by which full-
length GP is generated, GP-specific nucleotide se- EBO GP-specific mRNAs were isolated from 7 1 107
Vero cells infected with EBO at a m.o.i. of 1–10 PFU perquences were determined at the genomic and at the
mRNA level. Furthermore, transcription of GP mRNA and cell, 1 day p.i. Isolation was performed using the RNeasy
Total RNA Kit (Qiagen, Germany) according to the instruc-synthesis of the GP protein were studied in different ex-
pression systems. We show that synthesis of full-length tions of the supplier.
For the first-strand cDNA synthesis, 10 ml RNA solutionGP proceeds via RNA editing. Editing was observed not
only when GP was synthesized in EBO-infected cells, but corresponding to 1.4 1 107 cells was used and reverse
transcription was carried out with the primer N3 (oligo-also when the gene was transcribed using the vaccinia
virus/T7 system and a recombinant vaccinia virus. d(T)21), supplied with a 5*-terminal HindIII site. RNA there-
after was removed by incubation with 1 mg/ml RNAse at
377 for 30 min. Amplification of GP-specific mRNA viaMATERIALS AND METHODS
PCR was done using primers N1 and N3.
Viruses and cell lines PCR was carried out in a total volume of 100 ml reaction
mix containing 1–5 mg cDNA in 50 mM KCl, 10 mM Tris–The EBO subtype Zaire was received from the Institute
HCl (pH 8.3), 2 mM MgCl2 , 0.2 mM of each deoxynucleo-of Virology (Sergiev Posad, Russia). This virus was once
tide, and 0.3 mM of each primer. The reaction mix waspassaged in Macaca rhesus before use. EBO virus was
heated at 957 for 10 min and Taq polymerase (2.5 U/100cultured in Vero cells and purified from the tissue culture
ml; ‘‘hot start PCR’’) was added. Thirty-five cycles of DNAliquid as described previously (Volchkov et al., 1992). The
amplification were performed. The cycling program wasvaccinia virus strain WR and recombinant vaccinia virus
947 for 1 min, 707 for 1 min, and 727 for 1 min. Thereafter,vTF7-3 (kindly provided by Dr. B. Moss, Bethesda, MD)
samples were incubated at 727 for 10 min. All compo-were propagated in E6 cells, a cloned cell line of Vero
nents for PCR were obtained by Perkin–Elmer Cetus; thecells (ATCC CRL 1586). The recombinant vaccinia viruses
described protocol is a modified version of the RNA PCRwere propagated in CV-1 cells as described by Mackett
protocol recommended by Perkin–Elmer Cetus. Theet al. (1986). RK13, CV-1, HeLa, and TK-143 cell lines
products of PCR reaction were purified (QIAquick Spinwere maintained in Dulbecco’s medium containing 10%
PCR Purification Kit, Qiagen, Germany), and DNA wasFCS (fetal bovine serum, GIBCO, Germany).
used directly for sequencing, for repeated PCR reactions,
or for cloning in plasmid vectors. The nucleotide se-Molecular cloning and sequencing of viral RNA
quence of the region where ORF I and ORF II overlapped
(Fig. 1A) was determined by the Sanger techniqueThe construction and identification of cDNA clones of
EBO have been described previously (Volchkov et al., (Sanger et al., 1977) utilizing the primers N4 and N5 with
the sequence 5*-CGGACTCTGACCACTGAT (comple-1992). The nucleotide sequence of the GP gene was
determined by sequencing the inserts of the plasmids mentary to nucleotides 1108 to 1091) and 5*-TCGTGG-
CAGAGGGAGTGT (complementary to nucleotides 1412pEB137, pEB102, and pEB67. DNA sequence of the GP
gene was determined for both strands. Sequence analy- to 1395), respectively.
sis was performed according to Maxam and Gilbert
(1980). The sequence of the EBO GP gene strain Zaire Construction of recombinant plasmids
had been deposited at GenBank under Accession No.
U31033. The entire ORF of the EBO GP gene was synthesized
from purified vRNA or mRNA by the PCR technique asGenomic RNA of EBO was isolated from purified virus
by centrifugation on cesium chloride gradients as de- described above. In general the recombinant DNA proce-
dures were run as described by Sambrook et al. (1989).scribed previously (Volchkov et al., 1992). This RNA was
used for the construction of a cDNA library using random PCR products were digested with BamHI and HindIII
and ligated into the plasmid pGEM3Zf(/) that had beenprimers and a reverse transcriptase from avian myelo-
blastosis virus. RNA–cDNA hybrids from the cDNA li- digested with BamHI and HindIII. The vector contains a
T7 phage RNA polymerase promoter which was used forbrary were used for the amplification of the GP gene with
synthetic oligonucleotide primers: N1 with the sequence synthesizing the EBO GP RNA with T7 polymerase in
vitro and in vivo using the vaccinia virus/T7 polymerase5* - GAAGGATCCTGTGGGGCAACAACACAATG (mRNA
sense, nucleotides 114 to 142), supplied with a 5*-termi- expression system. The resulting recombinant plasmids
containing the entire GP coding sequence of EBO vRNAnal BamHI site; N2, 5*-AAAAAGCTTCTTTCCCTTGTC-
ACTAAA (complementary to nucleotides 2492 to 2466, were designated pGEM-mGP7 (7A’s), the plasmid con-
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taining the sequence of GP mRNA coding for the full- Construction of recombinant vaccinia viruses and
isolation of RNAlength GP (8A’s) was designated pGEM-mGP8.
The GP-specific inserts were cut out from the plasmids
Recombinant vaccinia viruses were generated by ho-
pGEM-mGP7 and pGEM-mGP8 with BamHI and HindIII,
mologous recombination between tk regions in the re-
the ends of the fragments were filled up by Klenow frag-
combinant plasmids pSC-mGP7 (7A’s at the editing site)
ment of DNA polymerase I and ligated into the Sma1
or pSC-mGP8 (8A’s) and the genomic DNA of vaccinia
restriction site of the vector pSC11 (Promega, Madison,
virus (WR strain) as described by Chakrabarti et al. (1985)
WI). The obtained recombinant plasmids, pSC-mGP7 and
using the lipofectin transfection method (Felgner et al.,
pSC-mGP8, were used for the generation of recombinant
1987). Recombinant viruses were plaque-purified one
vaccinia viruses.
time on TK-143 cells and four times on CV-1 cells using
b-galactosidase-positive plaques for selection. Recombi-
In vitro transcription/translation nant vaccinia viruses which were derived from pSC-
mGP7 were designated vSCGP7 and those derived from
For in vitro translation, a coupled transcription and
plasmid pSC-mGP8 were designated vSCGP8. Expres-
translation kit (TNT, Promega) was used. GP mRNA was
sion of GP was performed by infecting 1 1 106 HeLa
transcribed from 5 mg of recombinant plasmids pGEM-
cells with vSCGP7 or vSCGP8 at an m.o.i. of 10 PFU per
mGP7 or pGEM-mGP8 according to the instructions of
cell. After 16 to 18 hr p.i. infected HeLa cells and medium
the supplier and translated directly with a rabbit reticulo-
were harvested separately and analyzed for expression
cyte lysate system. One-fifth volume of each reaction was
of GP.
analyzed by 10% SDS–PAGE and autoradiography.
EBO GP mRNAs from infected HeLa or RK13 cells were
EBO GP-specific mRNAs transcribed by T7 RNA poly-
purified as described above.
merase from plasmids pGEM-mGP7 or pGEM-mGP8
were purified as described above (RNeasy Kit, Qiagen) Immunoblot analyses
followed by digestion of plasmid DNA with RQ1 RNase-
Lysates from 1.4 1 105 infected cells (RK13 or HeLa)free DNase (Promega) at a concentration 2 units/mg plas-
were separated on 10% SDS–PAGE as described bymid DNA for 30 min at 377.
Laemmli (1970) and blotted onto PVDF membranes (Milli-
pore) by the semidry technique. When secreted sGP wasPrimer extension method
analyzed, the supernatant from 1 1 106 infected cells
was harvested (2 ml), and 20 ml was loaded onto the gel.The primer extension procedures were carried out es-
Immunodetection was performed using either a mousesentially as described by Pelet et al. (1991), except that
anti-EBO serum (1:1000) or a horse anti-EBO serum20 mg of purified RNA (RNeasy Kit Qiagen) was used in
(1:2000) (kindly provided by Dr. I. Borisevich, Sergiev Po-the presence of 0.5 mM of each dNTP and 0.8 mM
sad, Russia) and a rabbit anti-mouse or rabbit anti-horseddGTP. The control reaction included the same amount
secondary antibody coupled to horseradish peroxidaseof RNA from uninfected cells. The following primers were
(1:5000). Bound secondary antibody was detected by ECLused: N6 5*-GAATTTTTCTAGTGAGG (complementary to
technique (Amersham).nucleotides 1043 to 1027) and as a negative control N7
5*-TACTCTGTCTCATTGGTT (complementary to nucleo-
RESULTStides 834 to 817). The 3* end of N6 is located just down-
stream of the editing site.
Molecular cloning and sequencing of the entire GP
gene from vRNA
Transient expression with T7 polymerase/vaccinia
The sequence of the GP gene of EBO subtype Zairevirus
has been determined as described under Materials and
Methods and has been deposited at GenBank (Acces-For transient expression of GP, 1 1 106 HeLa cells
were infected with vTF7-3 at an m.o.i. of 10 PFU/cell. At sion No. U31033; Volchkov et al., 1993). As already
pointed out, the sequence was identical to that published1 hr p.i., the virus inoculum was replaced by the transfec-
tion inoculum containing 5 mg recombinant plasmids by Sanchez et al. (1993), with one important difference.
At position 1019 to 1025 we found seven instead of eightpGEM-mGP7 or pGEM-mGP8 and 5 ml lipofectin (BRL)
(Felgner et al., 1987). At 16 to 18 hr after transfection, consecutive A’s (mRNA sense). The amino acid se-
quence deduced from the nucleotide sequence showedmedium and cells were harvested separately and ana-
lyzed for expression of GP. two large ORFs present in different frames. The first ORF
extends from the ATG codon at position 2 or, more likely,EBO GP-specific mRNAs from transfected HeLa or
RK13 cells were purified as described above (RNeasy from ATG at position 142 (Sanchez et al., 1993) to the
TAA at position 1232. This ORF is capable to encode aKit, Qiagen) followed by digestion of DNA with RQ1
RNase-free DNase (Promega) for 30 min at 377, 2 units/ protein of 410 or 364 aa, respectively. A second ORF
consisting of 382 aa (ORFII) was found between nucleo-mg plasmid DNA.
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FIG. 1. Schematic representation of the EBO GP gene, its ORFs, and its mRNAs. (A) sGP represents the mRNA which is an exact copy of the
genomic RNA, coding for the sGP protein. The two predicted overlapping ORFs in frame (0) and (01) are shown as boxes. (B) GP represents the
mRNA which is edited by insertion of one A residue coding for the full-length GP. The asterisk under the fusion ORF I–II indicates the position of
the editing site. Nucleotide positions are numbered. (C) The nucleotide sequence and the deduced amino acid sequence of the EBO GP editing
site without and with the A insertion. The point of transition from ORF I to ORF II is boxed.
tides 1021 to 2166 in (0)1 reading frame to the first ORF mRNA’s in EBO-infected cells contained one nontem-
plate A residue at this specific site. Only these 20% of(Fig. 1A). None of these two ORFs was able to encode
a protein of the size of GP found in virions (approx 125– GP mRNAs are able to encode full-length GP of 676 aa
because insertion of the additional A results in a140 kDa) (Elliott et al., 1985). To exclude the possibility
that the sequence difference between both studies was frameshift of ORF I to ORF II. Eighty percent of the ana-
lyzed mRNA clones encode presumably the nonstructuralthe result of a cloning artifact, multiple clones indepen-
dently isolated have been analyzed. Forty cDNA clones second glycoprotein (sGP). As indicated by the nucleo-
tide sequence sGP is identical to the N-terminal 294 aacontaining the GP gene were sequenced, all of them
showed only seven consecutive A’s (mRNA sense) in the of GP and contains additional 70 aa which are encoded
by the end of ORF I. These aa do not occur in GP becauseabove-mentioned region. This observation indicates that
the GP gene of the virus analyzed in our study contains the additional A shifted the reading frame to ORF II before
ORFI is closed. The predicted aa sequence shows alsoa stretch of seven A’s at position 1019–1025 (mRNA
sense). that sGP does not contain the GP membrane anchor
(Volchkov et al., 1992; Sanchez et al., 1993). However,
since it has the same N-terminal signal sequence asMolecular cloning and sequencing of the entire GP
full-length GP, sGP should be translocated into the ERgene from mRNAs
(Sanchez et al., 1993). This concept is compatible with
mRNA was isolated from EBO strain Zaire-infected the observation that sGP is secreted into the medium of
Vero cells and transcribed into cDNA, and GP-specific infected cells (Peters et al., 1994).
cDNA was amplified by PCR. Resulting PCR fragments For further investigation, the GP sequence was cloned
were cloned into the vector pGEM3Zf(/), and recombi- into several expression plasmid vectors containing either
nant plasmids were analyzed by enzymatic sequencing 7A’s (pGEM-mGP7, pSC-mGP7) or 8A’s (pGEM-mGP8,
(Sanger et al., 1977). The sequences of the 40 analyzed pSC-mGP8) at the editing site.
clones differed from each other only by the number of A
residues present between nucleotides 1018 and 1026 In vitro translation of GP RNA transcripts synthesized
(mRNA sense, mRNA numeration). In seven cases eight using T7 RNA polymerase
A residues could be identified, whereas all others con-
tained seven A’s representing exact copies of the vRNA In vitro translation of pGEM-mGP8 (8A’s, correspond-
ing to the edited mRNA species) resulted in the formationtemplate.
These data indicated that approx 20% of GP-specific of three proteins: a major 75-kDa protein, a second poly-
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tion of both plasmids is presumably the product of the
ORF II starting with the internal ATG codon at position
1186, since all other ATG codons will not give rise to
a protein of the detected size. The occurrence of the
additional GP-specific proteins during translation of
pGEM-mGP7 (75 kDa) and pGEM-mGP8 (32 kDa) was
unexpected and suggested either RNA editing as shown
for the EBO mRNA in infected cells (see above) or transla-
tional frameshifting.
In order to prove the first hypothesis a primer exten-
sion method was used as described by Pelet et al. (1991).
Extension of the primer across the editing site of recom-
binant RNA (cRNA) yielded a major band at position 0
corresponding to the unaltered RNA (ddGTP was in-
cluded in the reverse transcription reaction so that syn-
thesis would terminate at the first C upstream of the
insertion site, Fig. 2B). An additional weaker signal oc-
curred that represented GP cRNA elongated by one nu-
cleotide, and this was obviously the result of editing by
the T7 polymerase. As shown in Fig. 2C (lane 2), primer
extension analysis of a region with no history for editing
events yielded only a single band at the expected posi-
tion. It is therefore clear that insertion of one nucleotide
was the predominant editing event. An insertion of two
nucleotides was also detectable (data not shown). It was
not possible to unambiguously identify cRNA species
with deletions because a ladder of interfering shorter
bands were detected also in negative controls. These
bands are likely to be degradation products of the primer,
since shorter minor bands were also detected when the
primers were electrophoresed without extension (data
not shown). These results indicate that the 75-kDa pro-FIG. 2. In vitro analysis of protein and mRNA of EBO GP. (A) Expres-
tein found after in vitro transcription/translation of pGEM-sion of EBO GP from in vitro transcribed GP mRNA. The plasmids
mGP7 (Fig. 2A, lane 1) is derived from a mRNA speciespGEM-mGP7 (7A’s) and pGEM-mGP8 (8A’s) were constructed by in-
serting cDNA from EBO GP mRNA into plasmid pGEM3Zf(/). Plasmids with an additional nucleotide at the editing site leading
were transcribed in vitro with T7 RNA polymerase and translated by a to an ORF which encodes full-length GP. In analogy, the
rabbit reticulocyte lysate. Lane 1, plasmid pGEM-mGP7 (7A’s); lane 2, 32-kDa protein observed after in vitro transcription/trans-pGEM3Zf(/) as a control; lane 3, pGEM-mGP8 (8A’s). The positions of
lation of pGEM-mGP8 must be explained by a mRNAthe GP, sGP, GP-specific proteins 40k or 32k, and molecular mass
with an extra nucleotide in the region of the editing sitestandards are indicated. (B) Limited primer extension analysis of the
GP mRNA synthesized by T7 RNA polymerase. The mRNA sequence (Fig. 2A, lane 3). This insertion leads to the termination
of GP gene (position 1016–1042) is depicted, and the insertion site is of the ORF I just downstream of the editing site (stop
indicated with an asterisk. The underlined primer is extended by RT codon at position 1073). The expected size of the proteinin the presence of ddGTP which terminates extension at the first C
corresponded to the observed 32-kDa band.residue upstream of the insertion site. (C) Two different regions of GP
mRNA were analyzed by primer extension: editing site of pGEM-mGP8
(lane 1), of pGEM-mGP7 (lane 3) with primer N6 and a region with no Expression of GP gene with the vaccinia/T7
history for editing (nt 808–836) (lane 2) with primer N7. The lines on
polymerase expression systemthe left and right refer to the various primer extension products.
The expression of the EBO GP gene was then exam-
ined using the vaccinia virus/T7 RNA polymerase expres-peptide with approx 40 kDa, and a third 32-kDa protein
(Fig. 2A). Translation of pGEM-mGP7 (7A’s) resulted in a sion system (Fuerst et al., 1986). The plasmids pGEM-
mGP7 and pGEM-mGP8, containing the GP gene down-major polypeptide band migrating at approx 42 kDa
(sGP), a polypeptide with approx 40 kDa, and an addi- stream of the T7 RNA polymerase promoter in the
pGEM3Zf(/) vector, were transfected into HeLa or rabbittional longer protein with a Mr of approx 75 kDa corre-
sponding to the unglycosilated EBO GP. The amount of kidney (RK13) cells which had previously been infected
with vTF7-3 (Lefkowitz et al., 1990). Transfected cells andGP observed after translation of pGEM-mGP7 was ap-
prox 5% compared to the amount of GP expressed by supernatants were harvested 16–18 hr posttransfection.
Proteins were analyzed by SDS–PAGE and Western blot.pGEM-mGP8. The 40-kDa protein detected after transla-
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transfected HeLa cells, and 80 GP-specific cDNA clones
were sequenced. These clones differed only in the
amount of A residues at the editing site: two were found
with an additional A (corresponding to mRNA2), one con-
tained nine A’s, two contained only six A’s, whereas all
others were found to be complementary copies of the
plasmid pGEM-mGP7 (Fig. 3B). This result indicated that,
indeed, edited mRNA was present which allowed the
synthesis of full-length GP.
The amount of full-length GP was 5–10% when com-
pared to the expression of GP by pGEM-mGP8. The GP
expression products obtained with the vaccinia/T7 poly-
merase system differed in size from GP transcribed in
vitro. Whereas the longer expression product of pGEM-
mGP8 migrated at 75 kDa when synthesized in vitro (Fig.
2A, lane 3), expression of the full-length GP with the
vaccinia/T7 polymerase system resulted in the described
two forms migrating at 110 and 125–140 kDa. Likewise,
sGP had a size of 42 kDa after in vitro translation and
approx 50 kDa in the vaccinia/T7 system. These differ-
ences were due to glycosylation of the proteins as shown
below (Fig. 4).
sGP could not be detected in purified EBO virions (El-
liott et al., 1985; Chepurnov et al., 1994), indicating that
it is a nonstructural secreted glycoprotein (Peters et al.,
1994).
Expression of GP by recombinant vaccinia virusesFIG. 3. Analysis of in vivo expressed GP. (A) Western blot analysis.
Cell lysates of HeLa or RK13 cells either transfected by pGEM-mGP7
or pGEM-mGP8 or infected by recombinant vaccinia viruses vSCGP7 Since T7 DNA-dependent RNA polymerase was shown
or vSCGP8 were separated by SDS–PAGE and blotted onto PVDF to edit the EBO-specific cDNA constructs, it was of inter-
membranes prior to probing with anti-EBO antiserum. Lanes 1–5, HeLa est to investigate another RNA polymerase for its capac-
cells; lanes 6–8, RK13 cells. Lane 1, pGEM-mGP8 transfected; lane 2,
ity to edit the GP gene. For this purpose recombinantpGEM-mGP7 transfected; lane 3, control (vTF7-3 infected); lane 4,
vaccinia viruses were constructed containing either GPvSCGP8 infected, lane 5, vSCGP7 infected; lane 6, control (vTF7-3 in-
fected); lane 7, vSCGP7 infected; lane 8, vSCGP8 infected. The positions mRNA1 (7A’s) or mRNA2 (8A’s). HeLa cells and RK13
of GP, sGP, and molecular mass standards are indicated. (B) Sequence cells were infected with the resulting recombinant vi-
of GP-specific mRNA clones obtained from vaccinia virus/T7 expres- ruses designated vSCGP7 and vSCGP8 and analyzed for
sion system. The nucleotide sequence of GP cDNA clones derived
expression of GP gene products by immunoblot analysisfrom different mRNA species transcribed in vaccinia virus/T7 expres-
(Figs. 3A, 4A and 4B). Two EBO-specific bands weresion system in the region of nucleotides 996–1039 are shown to illus-
trate the 6, 7, 8, or 9 A residues in the EBO GP editing site. The A’s at detected in the cell lysates infected by vSCGP8 (Fig. 3A,
positions 1019–1024 are marked. lanes 4 and 8). Mr of both GP species coincided with
those obtained by transient expression of pGEM-mGP8
(Fig. 3A, lane 1). However, the amount of GP was higher
Expression of pGEM-mGP8 resulted in two EBO-specific after expression from recombinant vaccinia viruses.
proteins migrating at approx 125 and 110 kDa in HeLa When HeLa or RK13 cells were infected with vSCGP7
cells as shown in Fig. 3, lane 1, or 140 and 110 kDa in (genomic sequence), the ratio between sGP and full-
RK13 cells (data not shown). As shown below, endo H length GP was different from that obtained in the vac-
digestion revealed that the 110- and the 125- to 140- cinia/T7 system. Whereas the amount of full-length GP
kDa species represented the high mannose and mature expressed from vSCGP7 was decreased, the expression
forms of GP, respectively. rate of secreted sGP was higher compared to the vac-
When pGEM-mGP7 was used, the main GP-specific cinia/T7 system (data not shown). Since the experiments
expression product migrated at approx 50 kDa, but addi- were performed in the same cells (HeLa or RK13), the
tionally both forms of full-length GP were present, which only difference in the synthesis of GP was at the level
were indistinguishable from pGEM-mGP8-derived GP. To of transcription of mRNA that was either catalyzed by
determine whether full-length GP produced under these T7 RNA polymerase or by vaccinia virus polymerase.
conditions was translated from edited mRNA, RNA Sequencing of 80 cDNA clones obtained from mRNA of
vSCGP7-infected cells showed that one clone containedwas isolated from vTF7-3-infected and pGEM-mGP7-
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indicating that these species represented the mature
forms of GP with complex type N-linked oligosaccha-
rides.
The size of the unglycosylated form of GP and the size
of the high mannose form were independent from the
cell type used for expression. However, the mature GP
expressed in RK13 cells migrated at 140 kDa in SDS–
PAGE, whereas GP in HeLa cells had a size of 125 kDa.
This difference is probably due to variations in complex
type N-glycosylation of the two cell lines. The 140-kDa
form detected in RK13 cells comigrated with GP incorpo-
rated into the virions.
Supernatants of vSCGP7-infected cells were shown to
contain sGP migrating as a diffuse band of approx 50–
55 kDa (Fig. 4B, lane 3). Intracellular sGP migrated as a
band of 50 kDa. Endo H digestion of lysates and superna-
tants of cells infected with vSCGP7 revealed that the
secreted sGP was resistant to endo H, whereas the
smaller intracellular form was converted to a 40-kDa pro-
tein (Fig. 4B, lanes 3–6). Only trace amounts of the ma-
ture sGP were detected intracellularly (Fig. 3A, lanes 2,
5, and 7). As can be seen in Fig. 4B, (lanes 3 and 6), the
major part of sGP synthesized in cells accumulates in
the culture medium. Quantitative analysis showed that
the ratio between secreted sGP and intracellular form of
sGP is approximately 25:1. These data indicate that sGP
is rapidly secreted after processing to the complex form.
FIG. 4. Endo H digestion analysis of GP expressed in HeLa or RK13 In addition to sGP, another GP-specific protein could be
cells. Cells were infected with vSCGP7, vSCGP8, or with vTF7-3. At 18 detected in the supernatant of vSCGP7 migrating at an
hr p.i. supernatants or cells were lyzed and subjected to glycosidase Mr of approx 28 kDa (Fig. 4B, ssGP). This protein is possi-treatment. Digested samples were separated by SDS–PAGE and blot-
bly the translation product of GP-specific mRNAs with ated onto PVDF membranes. Detection of GP-specific proteins was per-
deletion of one or an insertion of two A residues at theformed with a horse anti-EBO antiserum. GP-specific proteins digested
by Endo H are marked by asterisks. The position of the GP, sGP, super editing site, that were detected when the transcripts of
sGP (ssGP), and molecular mass standards are indicated. (A) Analysis the 7A’s constract were sequenced. Both mutations
of GP expression in RK13 (lanes 1–5) or HeLa cells (lanes 6–10). Lane would lead to a termination of translation at position
1, control (vTF7-3 infected); lane 2, vSCGP8 infected; lane 3, vSCGP8-
1073 and therefore to the synthesis of proteins with theinfected cells after digestion with endo H; lane 4, vSCGP7-infected
detected size (see above). However, it is also possiblecells; lane 5, vSCGP7-infected cells after digestion with endo H; lane
6, vSCGP7-infected cells after digestion with endo H; lane 7, vSCGP7- that this protein is the translation product of a mRNA that
infected cells; lane 8, vSCGP8-infected cells after digestion with endo arises when the GP editing site is used as a stop signal
H; lane 9, vSCGP8-infected cells; lane 10, control (vTF7-3-infected cells). by the vaccinia virus polymerase (Moss, 1990). Further
(B) Analysis of GP-specific proteins in the supernatant of HeLa cells.
studies are needed to examine whether ssGP occurs asLane 1, supernatant of vTF7-3-infected cells after digestion with endo
a second nonstructural protein in EBO-infected cells orH; lane 2, supernatant of vTF7-3-infected cells; lane 3, supernatant of
vSCGP7-infected cells; lane 4, supernatant of vSCGP7-infected cells whether it is observed only in vaccinia virus expression
after digestion with endo H; lane 5, vSCGP7-infected HeLa cells after systems.
digestion with endo H; lane 6, vSCGP7-infected HeLa cells; lane 7,
vTF7-3-infected cells after digestion with endo H.
DISCUSSION
GP (Mr 125–140 kDa) is the only surface protein ofan additional A residue, thus again supporting the view
that synthesis of full length GP is caused by editing of EBO. It is integrated into the viral membrane from which
it can be removed by bromelain treatment (Kiley et al.,the 7A’s stretch.
To investigate the nature of the two GP-specific pro- 1988). Nucleotide sequence analysis performed on EBO
strain Zaire revealed the presence of a stop codon inteins (110 and 125–140 kDa) found after expression from
recombinant vaccinia viruses, infected cell lysates were the middle of the GP gene (Volchkov et al., 1993). This
observation has now been confirmed on a total of 43digested with endoglycosidase H (endo H). Figure 4A
(lanes 3 and 8) shows that the 110-kDa species shifted cDNA clones, none of which showed a single ORF capa-
ble to encode a protein of the size of GP. From theseto 75 kDa corresponding to the unglycosylated GP. The
125- to 140-kDa forms were resistant to endo H digestion results it became clear that expression of EBO GP in-
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volves either translational frame shifting or RNA editing also result in deletions. Deletions were mainly found
when seven or more identical nucleotides (C) occurredat the level of transcription.
When GP-specific mRNA of EBO-infected cells was in the template.
To confirm the data derived from in vitro transcription/analyzed, 80% of the sequenced cDNA clones were
found to be exact copies of the viral genome. However, translation, GP was transcribed by vaccinia virus RNA
polymerase. Expression from recombinant vaccinia vi-20% contained eight instead of seven A residues at posi-
tions 1019 to 1026 resulting in a frameshift that allows ruses revealed that full-length GP was also obtained
when the 7A’s construct was used. Since the amount ofthe synthesis of full-length GP. These observations indi-
cate that synthesis of full-length GP involves editing by 8A’s mRNA species transcribed from the 7A’s virus was
lower than that observed in the T7-driven system, it wasthe viral polymerase. This concept is in agreement with
the latest work of Sanchez and co-workers. Although in not surprising that the amount of full-length GP was also
decreased.their original report on the genome of the Mayinga strain
of EBO GP was found to be encoded by a single ORF RNA editing has been described for a variety of para-
myxoviruses, such as simian virus 5 (SV5, Thomas et al.,(Sanchez et al., 1993), extension of their studies to sub-
types Reston and Sudan and recently to Zaire virus with 1988), Sendai virus (Vidal et al., 1990a), measles virus
(Cattaneo et al., 1989), mumps virus (Paterson and Lamb,a different passage history revealed that GP is expressed
by transcriptional editing from two ORFs (Peters et al., 1990; Takeuchi et al., 1990), and parainfluenza virus types
2 and 4 (Southern et al., 1990; Ohgimoto et al., 1990;1994, Sanchez et al., 1994). Thus, editing of the GP gene
appears to be a common trait of EBO, whereas it has so Kondo et al., 1990). With each of these viruses, editing
has been shown to occur by the insertion of an additionalfar not been observed with MBG.
The observation that, depending on the propagation G residue at the specific sequence 3*-UUU/CUCCC-5* of
the P gene. The P gene of paramyxoviruses is reportedhistory of the virus, the GP gene of the Zaire subtype
contains either 7U’s or 8U’s at the editing site is of consid- to be edited exclusively by viral RNA-dependent RNA
polymerases (Horikami and Moyer, 1991; Pelet et al.,erable interest. It remains to be seen whether these vari-
ants arise from each other by mutation or whether they 1991; Matsuoka et al., 1991; Vidal et al., 1990a). In con-
trast, the data presented here show that the editing sitesegregate from a mixed population during passage in
cell culture or in experimental animals. Obviously, the of EBO GP is also recognized by DNA-dependent RNA
polymerases. The mechanism by which editing of the GPdifferences in the replication strategies of both variants
may have important consequences for virus spread, gene occurs appears to be similar with RNA- and DNA-
dependent RNA polymerases, since both types of en-course of infection, and pathogenicity. Further studies
are needed to throw light on these problems. zymes insert exactly in the same region the same non-
template nucleotide (A). The detected editing site in EBOTo investigate the expression products of both types of
EBO GP mRNA, expression of GP was studied in several genomic RNA (7U’s) is different from the editing site
found in the P gene of paramyxoviruses, rather resem-expression systems, using two cDNA constructs: one
with 7A’s at the proposed editing site, corresponding to bling the polyadenylation site (transcription stop signal)
of EBO mRNAs (3*-UAAUUCUUUUUU, genomic sense).the genomic sequence, the other with 8A’s at the same
site, representing the edited mRNA species. Translation The EBO editing site is also similar to the transcription
stop signal of the vaccinia virus polymerase (3*-UUU-of the 8A’s species with an in vitro system using T7 DNA-
dependent RNA polymerase for transcription revealed UUNU) (Moss, 1990). Presumably, temporary pausing of
the viral RNA polymerase and both investigated DNA-the expected unglycosylated full-length GP at a size of
approx 75 kDa (Fig. 2A, lane 3). Expression of the 7A’s dependent RNA polymerases at the editing site of the
EBO GP gene enables the transcription complex to slipconstruct led to sGP (42 kDa) corresponding to ORFI.
Surprisingly, also full-length GP was detected after in backward or forward on the vRNA template before the
next nucleotide is incorporated. This mechanism wasvitro transcription/translation of the 7A’s construct.
Similar results were obtained when GP was synthe- described for editing of the P gene of paramyxoviruses
(Vidal et al., 1990b) and obviously could be used in edit-sized by the vaccinia virus/T7 system, suggesting that
the T7 RNA polymerase, like EBO polymerase in virus- ing of EBO GP. In this case the similarity with polyadenyl-
ation sites may at least partly explain the relatively broadinfected cells, was able to edit the GP gene. mRNA syn-
thesized by the T7 polymerase was analyzed by sequenc- spectrum of RNA polymerases recognizing the editing
site of EBO GP.ing and primer extension. Both methods detected edited
mRNA species. Two mRNA clones of 80 contained 8A’s Our data indicate that editing of the GP gene is most
likely the main source of the full-length GP in EBO-in-at the editing site allowing the synthesis of full-length
GP. In addition, 6A’s and 9A’s species could be detected, fected cells and in cells which were transfected with
pGEM-mGP7 or infected by vSCGP7. However, it is im-suggesting that editing may not lead in every case to a
(/)1 mutant mRNA but also provide (0)1 and (/)2 mu- portant to note that the proposed EBO GP editing site is
also well suited for a ribosomal frame shifting as showntants (Fig. 3B). Interestingly, Jacques et al. (1994) showed
that RNA editing in the P gene of paramyxoviruses may for mouse mammary tumor virus, simian T-cell leukemia
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dicate that the hairpin-like structure is supportive, but
not essential for editing.
In conclusion our data suggest that expression sys-
tems using T7 polymerase or vaccinia virus polymerase
are able to carry out frame shifting by RNA editing. Pre-
requisite for this editing, however, is a suitable editing
site like that found inside the EBO GP gene. Further
investigations are planned to study the influence of the
sequence context around the editing site including the
proposed secondary structure.
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